Muutke küpsiste eelistusi

E-raamat: Uncertain Precision: Managing Health Care with Personalized Technologies

(William Smilow Professor of Medicine and Genetics, Emeritus, Perelman School of Medicine, University of Pennsylvania.)
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 08-Jan-2026
  • Kirjastus: Oxford University Press Inc
  • Keel: eng
  • ISBN-13: 9780197796313
  • Formaat - EPUB+DRM
  • Hind: 31,38 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 08-Jan-2026
  • Kirjastus: Oxford University Press Inc
  • Keel: eng
  • ISBN-13: 9780197796313

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Uncertain Precision: Managing Health Care with Personalized Technologies explores the rapid evolution of precision medicine technologies like genome sequencing, AI, and gene therapies. Using clinical examples and expert insights, Dr. Reed E. Pyeritz examines their benefits, limitations, and integration into patient care.

The future of precision health care is being driven by the increasingly rapid evolution of technologies. Over the past century, health care has benefited tremendously from the steady introduction of new tools, such as imaging, vaccines, immunology, biochemical analysis, and drug development; more recently, emerging technologies have arisen rapidly, undergone swift validation, and experienced prompt application. However, these technologies and their results have uncertainties and impact all facets of precision patient management.

Uncertain Precision: Managing Health Care with Personalized Technologies provides an in-depth overview of precision medicine and its relationship with new technology, examining its current scope, benefits, and limitations. While new medical technologies can identify many individual traits that establish diagnoses, predict the course of illness, and recommend therapies, the tools and their results have uncertainties that the health care professional must anticipate and recognize.

Utilizing clinical examples from his own experience and insights from colleagues and other experts, Dr. Reed E. Pyeritz discusses key technologies, such as genome sequencing, artificial intelligence, targeting a patient's immune cells to cancer, and gene therapies. Timely and compelling, Uncertain Precision is an essential resource for anyone interested in the future of health care and the role of precision medicine in delivering tailored medical solutions.
1. Introduction
2. Personalized Medicine Cannot Always be Precise, But Precision Medicine
Must Always Be Personalized
3. Uncertainty as a Fact of Life
4. Uncertainty Pervades All Healthcare
5. Artificial Intelligence: Origins, Applications and Challenges
6. How Artificial Intelligence Enhances Healthcare
7. Our -Omics
8. Our Genomes
9. Exploring Our Genes
10. Faster, Higher, Stronger: Uncertainties in Athletics
11. Is Ageing a Terminal Disease?
12. Future Casting
13. Departing Thoughts
Reed E. Pyeritz is the William Smilow Professor of Medicine and Genetics, Emeritus, at the Perelman School of Medicine, University of Pennsylvania. He received his B.S. from the University of Delaware, a Ph.D. in biological chemistry from Harvard University, and an M.D. from Harvard Medical School. His clinical practice focuses on adults with hereditary disorders, especially of the cardiovascular system. His research contributed to the lifespan of people with Marfan syndrome improving from the mid-forties to the seventies. Long interested in medical economics and ethics, he has studied the professional obligations of providers of genetics services and the financial influences that limit access. He has published over 700 research studies, reviews, and chapters, and co-edits Principles and Practice of Medical Genetics and Genomics.